RKL Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.1M Buy
2,286
+9
+0.4% +$9.12K 0.19% 65
2025
Q4
$2.45M Sell
2,277
-331
-13% -$316K 0.2% 62
2025
Q3
$1.99M Sell
2,608
-174
-6% -$129K 0.17% 69
2025
Q2
$2.17M Sell
2,782
-30
-1% -$23.3K 0.19% 64
2025
Q1
$2.32M Buy
2,812
+86
+3% +$71.6K 0.22% 63
2024
Q4
$2.1M Sell
2,726
-92
-3% -$76.2K 0.19% 68
2024
Q3
$2.5M Sell
2,818
-86
-3% -$77.3K 0.23% 55
2024
Q2
$2.63M Sell
2,904
-294
-9% -$235K 0.25% 53
2024
Q1
$2.49M Buy
3,198
+194
+6% +$138K 0.25% 53
2023
Q4
$1.75M Buy
3,004
+1,964
+189% +$1.15M 0.19% 62
2023
Q3
$559K Buy
1,040
+93
+10% +$47.9K 0.07% 90
2023
Q2
$444K Sell
947
-31
-3% -$13K 0.05% 101
2023
Q1
$336K Sell
978
-35
-3% -$11.8K 0.04% 109
2022
Q4
$371K Sell
1,013
-21
-2% -$7.45K 0.05% 107
2022
Q3
$334K Buy
1,034
+12
+1% +$3.8K 0.05% 109
2022
Q2
$331K Sell
1,022
-43
-4% -$12.9K 0.05% 110
2022
Q1
$305K Buy
1,065
+258
+32% +$66.4K 0.04% 119
2021
Q4
$223K Buy
+807
New +$205K 0.03% 123
2021
Q3
Sell
-2,669
Closed -$613K 127
2021
Q2
$613K Buy
+2,669
New +$536K 0.08% 87
2021
Q1
Sell
-1,263
Closed -$213K 131
2020
Q4
$213K Buy
+1,263
New +$189K 0.03% 121
2017
Q4
Sell
-2,755
Closed -$237K 144
2017
Q3
$237K Buy
+2,755
New +$226K 0.07% 139

Other funds holding LLY

RKL Wealth Management's LLY Position: Q1 2026 in Review

RKL Wealth Management increased its Eli Lilly (LLY) stake by 0.4% in Q1 2026, buying an estimated $9.12K and bringing the position to 2,286 shares worth $2.1M. The position accounts for 0.19% of the portfolio, ranked #65.

RKL Wealth Management first reported a position in LLY in Q3 2017 and has held it in 21 quarters since. The position peaked at $2.63M in Q2 2024. 4,354 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • RKL Wealth Management held 2,286 shares of Eli Lilly worth $2.1M as of Q1 2026.
  • RKL Wealth Management bought 9 Eli Lilly shares in Q1 2026, an estimated $9.12K.
  • Eli Lilly made up 0.19% of RKL Wealth Management's portfolio in Q1 2026, its #65 holding.
  • RKL Wealth Management first reported a position in Eli Lilly in Q3 2017 and has held it in 21 quarters since.
  • RKL Wealth Management's Eli Lilly position peaked at $2.63M in Q2 2024.
  • 4,354 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on RKL Wealth Management's 13F filing for Q1 2026, filed 24 Apr 2026.